Goldman Sachs analyst Kash Rangan updated the investment firm's outlook on Dynatrace Inc. (NYSE: NYSE:DT), increasing the ...
Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback